Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2 is a research paper published in Molecules (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Bayer AG
Grant: OGI-196
Bayer AG
Grant: 875510
EUbOPEN: Enabling and Unlocking biology in the OPEN
Bayer AG
Grant: 2018-IDG-1030
Bayer AG
Grant: 1U24DK116204-01
Illuminating Function of the Understudied Druggable Kinome
Bayer AG
Grant: AL190107
Bayer AG
Grant: S10OD032476
National Institutes of Health
Grant: 1S10OD032476-01
Request for a 500 MHz NMR console and nitrogen-cooled cryoprobe
Fields of Study
Keywords